Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

sun_pharma_logo

Sun Pharma takes on Novartis in the US with generic Glivec

February 2, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Gleevec, Novartis, Sun Pharma

Mumbai-based drug manufacturer Sun Pharma has launched a generic version of Glivec, for the same indications for which the former …
News
bms_logo_square

Europe approves BMS hep C drug for HIV and liver transplant patients

February 1, 2016 Research and Development, Sales and Marketing Bristol-Myers Squibb, daclatasvir, daklinza

The European Commission has approved the expanded use of Bristol Myers-Squibb’s hepatitis C drug Daklinza (daclatasvir), to include liver transplant …
News
abbvie

AbbVie posts strong Q4 results

February 1, 2016 Sales and Marketing AbbVie, Humira, Viekira Pak

AbbVie managed to meet or beat analysts’ expectations in its Q4 financial results report, with extremely strong Humira sales contributing …
News
corbett_issy

PwC appoints Issy Corbett as healthcare M&A partner

February 1, 2016 Sales and Marketing pwC

PwC has appointed Issy Corbett as a partner to lead its healthcare M&A team.Corbett joins PwC from Rothschild, where he …
Appointment
Westminster

Ministers reject bid to revive Off Patent Drugs Bill

February 1, 2016 Research and Development, Sales and Marketing Access to Medical Treatments (Innovation) Bill, Off Patent Drugs Bill, Off-Patent Drugs Bill, george freeman, parliament, repurposing drugs

Ministers have rejected amendments to a proposed Parliamentary Bill that sought to reintroduce elements of the Off Patent Drugs Bill, …
News
EMA inside

Actelion’s Uptravi and rare bleeding disorder drug get positive EMA decisions

February 1, 2016 Sales and Marketing CHMP, EMA, Uptravi, pulmonary arterial hypertension, selexipag

The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the EMA, has issued positive opinions on …
News
Empliciti pack shot

EMA fast-tracks BMS multiple myeloma drug

February 1, 2016 Sales and Marketing AbbVie, BMS, Bristol-Myers Squibb, EMA, Empliciti, myeloma

The EMA has recommended granting a marketing authorisation for Bristol Myers-Squibb and AbbVie’s immunotherapy Empliciti for the treatment of multiple myeloma. The …
News
john_milligan_gilead_sciences

Gilead Sciences names John Milligan new CEO

January 29, 2016 Medical Communications, Sales and Marketing Gilead Sciences, John Martin, John Milligan

Gilead Sciences has announced that chairman and chief executive John Martin is to step down after 20 years at the …
Appointment
allergan

Allergan’s depression drug awarded FDA Breakthrough Therapy status

January 29, 2016 Research and Development, Sales and Marketing Allergan, depression, rapastinel

While still adjusting to life as part of Pfizer, Allergan has received some good news in the form of the …
News
business_generic

Pharma: How to make mergers work

January 29, 2016 Sales and Marketing mergers and acquisitions

Pharma is no stranger to bursts of M&A activity.
Feature
Merck image

MSD gets FDA approval for hepatitis C drug Zepatier

January 29, 2016 Medical Communications, Sales and Marketing FDA, MSD, Zepatier, hepatitis C

The competitive hepatitis C market is to get another contender, with FDA approving MSD’s new combo treatment Zepatier (elbasvir and …
News
dr_reddys_building

Indian pharma market set to grow to $55 billion by 2020

January 28, 2016 Sales and Marketing GlobalData

The pharmaceuticals market in India, valued at $20 billion in 2015, is set to soar to $55 billion by 2020, …
News
roche_glass_building

Roche beats estimates with strong 2015 sales

January 28, 2016 Medical Communications, Sales and Marketing Esbriet, Herceptin, Roche, avastin

Roche reported full-year financial results today, beating analysts’ estimates, with the Swiss drugmaker announcing Group sales increases for 2015 in …
News
Lynparza

AZ’s Lynparza gets prostate cancer breakthrough status

January 28, 2016 Sales and Marketing AstraZeneca, Breakthrough Therapy Designation, FDA, lynparza, olaparib, prostate cancer

AstraZeneca’s Lynparza has been granted breakthrough therapy designation by the FDA as a monotherapy for the treatment of a specific …
News
Joseph Jimenez

Novartis braces for cuts after mixed 2015 performance

January 28, 2016 Sales and Marketing Novartis, financial results, revenue, sales

Net sales at Novartis fell by 5% in 2015 – prompting the company to make billion-dollar changes to its business …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026